DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- Research and development, 2025
- $146M
- YoY, 2025
- +75.2%
- 5-year CAGR
- +23.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $146M | +75.2% |
| 2024 | $83M | +153.1% |
| 2023 | $33M | +11.8% |
| 2022 | $29M | −37.2% |
| 2021 | $47M | −7.6% |
| 2020 | $51M | −14.5% |
| 2019 | $59M | +43.2% |
| 2018 | $41M | +48.2% |
| 2017 | $28M | +382.5% |
| 2016 | $5.8M | — |